FEB 22, 2021
Intracranial Pressure/Headache , Neuro-Ophthalmology/Orbit
In this interview from NANOS 2021, Dr. Julie Falardeau describes promising new treatments for the treatment of idiopathic intracranial hypertension. She highlights efficacy and safety data for a glucagon-like peptide-1 (GLP-1) agonist and a 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor.
Relevant Financial Disclosures: None